High recurrence of MYB-NFIB fusions and their ACC-specificity in the context of other types of head and neck neoplasms [4, 28] have encouraged various attempts to assess the diagnostic relevance of these genetic aberrations. This evidence concerns the gene NFIB and adrenal cortex carcinoma.